Last $102.56 USD
Change Today -0.32 / -0.31%
Volume 225.9K
As of 8:04 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

chemed corp (CHE) Snapshot

Open
$102.62
Previous Close
$102.88
Day High
$102.94
Day Low
$102.00
52 Week High
07/30/14 - $103.50
52 Week Low
10/29/13 - $64.16
Market Cap
1.8B
Average Volume 10 Days
227.1K
EPS TTM
$5.20
Shares Outstanding
17.3M
EX-Date
08/14/14
P/E TM
19.7x
Dividend
$0.88
Dividend Yield
0.80%
Current Stock Chart for CHEMED CORP (CHE)

chemed corp (CHE) Related Businessweek News

View More BusinessWeek News

chemed corp (CHE) Details

Chemed Corporation provides hospice and palliative care services in the United States. It operates in two segments, VITAS and Roto-Rooter. The company offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. It also provides plumbing and drain cleaning services to residential and commercial customers. Chemed Corporation was founded in 1970 and is based in Cincinnati, Ohio.

chemed corp (CHE) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $857.9K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $463.1K
Executive Vice President and Chief Executive ...
Total Annual Compensation: $610.5K
Executive Vice President, Chairman of Roto-Ro...
Total Annual Compensation: $314.4K
Principal Accounting Officer, Vice President ...
Total Annual Compensation: $237.7K
Compensation as of Fiscal Year 2013.

chemed corp (CHE) Key Developments

Chemed Corporation Declares Increase in Quarterly Dividend Payable on September 3, 2014

Chemed Corporation announced that the Board of Directors has declared a quarterly cash dividend of 22 cents per share on the Company's capital stock, payable on September 3, 2014, to shareholders of record as of August 18, 2014. This is a 2 cent, or 10.0%, increase over the 20 cent dividend paid in the second quarter of 2014. The previous dividend increase was in August 2013, when the Board raised the dividend from 18 cents to 20 cents per share. This represents the 173rd consecutive quarterly dividend paid by Chemed in its 43 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter.

Chemed Corp. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Earnings Guidance for the Full Year of 2014

Chemed Corp. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported income from operations of $41,519,000, income before income taxes of $39,846,000, net income of $24,363,000 or $1.36 diluted per share on service revenues and sales of $360,182,000 against income from operations of $23,891,000, income before income taxes of $39,846,000, net income of $14,608,000 or $0.79 diluted per share on service revenues and sales of $357,198,000 for the same period a year ago. EBITDA was $50,282,000 against $35,668,000 for the same period a year ago. Adjusted EBITDA was $52,213,000 against $52,943,000 for the same period a year ago. For the six months, the company reported income from operations of $78,171,000, income before income taxes of $73,499,000, net income of $44,937,000 or $2.48 diluted per share on service revenues and sales of $718,482,000 against income from operations of $64,744,000, income before income taxes of $60,355,000, net income of $36,886,000 or $1.94 diluted per share on service revenues and sales of $723,839,000 for the same period a year ago. Net cash provided by operating activities was $45,113,000 against $84,666,000 for the same period a year ago. Capital expenditures was $19,454,000 against $12,200,000 for the same period a year ago. EBITDA was $95,908,000 against $84,148,000 for the same period a year ago. Adjusted EBITDA was $99,885,000 against $104,239,000 for the same period a year ago. The company provides earnings guidance for the full year of 2014. Full-year 2014 revenue growth for VITAS, prior to Medicare Cap, is estimated to be in the range of 1% to 2%. Management estimates that full-year 2014 earnings per diluted share, excluding non-cash expense for stock options, the non-cash interest expense related to the accounting for convertible debt, litigation and other discrete items, will be in the range of $5.90 to $6.10. Full year adjusted EBITDA margin, prior to Medicare Cap, is estimated to be 14.5% to 15%. Medicare Cap is estimated to be $3.7 million in 2014. Roto-Rooter is forecasted to achieve full year 2014 revenue growth of 3% to 4%. This revenue estimate is based upon increased job pricing of approximately 2%. Adjusted EBITDA margin for 2014 is estimated in the range of 19.5% to 20%. Management estimates that full year 2014 earnings per diluted share, excluding noncash expense for stock options.

Chemed Corp. to Report Q2, 2014 Results on Jul 23, 2014

Chemed Corp. announced that they will report Q2, 2014 results at 5:00 PM, Eastern Standard Time on Jul 23, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CHE:US $102.56 USD -0.32

CHE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CHE.
View Industry Companies
 

Industry Analysis

CHE

Industry Average

Valuation CHE Industry Range
No financial data is available for CHE.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMED CORP, please visit www.chemed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.